Analgesia in anesthesia-free extracorporeal shock wave lithotripsy: a standardized protocol.

We treated 101 patients at our stone facility with the Dornier HM3 lithotriptor modified with the anesthesia-free design upgrade. A protocol designed by our anesthesiologists consisting of intravenous and intramuscular injections for sedation was used without any general or regional anesthesia required. Pre-medication with intramuscular meperidine and promethazine, and oral diazepam was sufficient sedation in 43 patients, while 37 required additional intravenous meperidine and/or midazolam during the procedure, 16 were treated with intraprocedural medication alone and 5 required no medication at all. Care before, during and after the procedure was rendered by the urology staff for patients in American Society of Anesthesiologists risk category I or II. Treatment was successfully completed in all patients without complications. We compared this group to the 99 patients treated consecutively before the modification. Voltage used, number of shocks and stone burden were comparable in the 2 groups but average treatment time was prolonged with the upgraded equipment (39.2 versus 27.1 minutes) to a significant degree (p less than 0.001).

Nonnarcotic analgesics and tricyclic antidepressants for the treatment of chronic nonmalignant pain.

Chronic nonmalignant pain is often characterized by multiple treatment failures, a pattern of maladaptive behavior, and depression. Often there is a history of inappropriate and excessive use of medications for pain. Prior and ongoing use of narcotics and sedatives acts to compound and aggravate the chronic pain syndrome. A first step in treatment is controlled withdrawal of these agents. Nonnarcotic analgesics, NSAIDs, and tricyclic antidepressants are commonly employed in patients with chronic pain. Effective use of these agents requires understanding of their pharmacokinetic and pharmacodynamic properties. Use of a fixed-time schedule is necessary to achieve an effective, sustained therapeutic response. Careful patient education and monitoring for side effects and toxicity are necessary, particularly in the elderly and patients with coexisting medical disorders. Incidence of side effects and toxicity may be reduced by choice of drug and modification of dosing regimen. Nonnarcotic analgesics, TCAs, and NSAIDs are seldom effective by themselves in resolving the pain and distress of patients with chronic nonmalignant pain. This is particularly true when maladaptive behavior coexists. A comprehensive multimodal pain management program encompassing additional pain-relieving strategies and behavior-modifying techniques should be considered and utilized in conjunction with medication.

Postoperative pain control with methadone following lower abdominal surgery.

STUDY OBJECTIVES: To describe a technique for the use of methadone during and following lower abdominal surgery that integrates its pharmacokinetic and pharmacodynamic properties with the objective of postoperative analgesia; to compare methadone with morphine for postoperative pain control. DESIGN: Randomized prospective clinical trial. Patients were not told which agent they received (single-blind). SETTING: Department of anesthesia and gynecology surgical service at a university medical center. PATIENTS: Forty women undergoing abdominal hysterectomy (n = 39) or myomectomy (n = 1). INTERVENTIONS: Patients received either methadone (Group 1) or morphine (Group 2) 20 mg intravenously (IV) following induction of anesthesia, additional IV opioid in the recovery room, and subsequent opioid as needed (PRN) intramuscularly (IM) on the postsurgical wards. MEASUREMENTS AND MAIN RESULTS: Pain was assessed using a visual analog scale (VAS). Respiratory rate, sedation, and hemodynamics were assessed frequently (at least every 4 hours). Patients were studied for 72 hours following recovery room discharge. Patients required less methadone than morphine in the recovery room (2.0 +/- 2.9 mg vs 4.4 +/- 2.9 mg). Patients requested less methadone than morphine for pain relief on the wards (4.5 +/- 4.2 mg vs 42.3 +/- 14.3 mg). Patients in the methadone group reported lower pain intensity by VAS (1.9 +/- 0.3 vs 3.4 +/- 0.6). These differences are statistically significant (p less than 0.01). CONCLUSION: Sustained analgesia with methadone is predicted by its pharmacokinetics. Patients who received 22 +/- 2.9 mg of IV methadone (combined intraoperative and recovery room doses) reported less pain and required minimal additional analgesic over the next 72 hours than did patients who received morphine. This is consistent with sustained therapeutic plasma levels due to methadone's long plasma half-life (54 +/- 20 hours). Use of methadone in this manner is an effective therapy for postoperative pain control and is not associated with toxicity or notable side effects.

Illness behavior, depression and anhedonia in myofascial face and back pain patients.

Levels of depression, anhedonia, and illness behavior, as well as clinical and demographic variables, were measured in two groups of patients with chronic pain, one with facial, the other with back pain. For the total sample, significant correlations (p less than 0.01) were found between illness behavior and pain estimate (r = 0.30), anhedonia and depression (r = 0.33), and pain estimate and pain duration (r = 0.31). Facial pain patients showed illness behavior most strongly related to estimate of pain severity (r = 0.62); back pain patients showed illness behavior significantly related to depression (r = 0.59). Results also show that the physical site of pain relates to illness behavior but not mood of chronic pain patients.